A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Diabetes is one of the most common chronic diseases which is encountered in our day to day life. Patients with diabetes ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Diabetes is one of the most common chronic illnesses impacting daily lives. Medically, diabetes is classified into two ...

World Diabetes Day, observed annually on November 14th, raises awareness about the escalating global diabetes epidemic. The ...

Type 2 diabetes 3. LADA About 90 percent of diabetics have Type 2 diabetes ... Anti-Retroviral Therapy), genetic conditions (MODY), or underlying health issues. Unlike primary diabetes, secondary ...